Edwards Lifesciences EBITDA 2010-2024 | EW

Edwards Lifesciences annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Edwards Lifesciences EBITDA for the quarter ending September 30, 2024 was $0.385B, a 4.39% decline year-over-year.
  • Edwards Lifesciences EBITDA for the twelve months ending September 30, 2024 was $1.773B, a 10.17% increase year-over-year.
  • Edwards Lifesciences 2023 annual EBITDA was $1.679B, a 11.07% decline from 2022.
  • Edwards Lifesciences 2022 annual EBITDA was $1.888B, a 3.45% increase from 2021.
  • Edwards Lifesciences 2021 annual EBITDA was $1.825B, a 81.64% increase from 2020.
Edwards Lifesciences Annual EBITDA
(Millions of US $)
2023 $1,679
2022 $1,888
2021 $1,825
2020 $1,005
2019 $1,236
2018 $826
2017 $1,171
2016 $855
2015 $709
2014 $561
2013 $535
2012 $474
2011 $358
2010 $341
2009 $297
Edwards Lifesciences Quarterly EBITDA
(Millions of US $)
2024-09-30 $385
2024-06-30 $409
2024-03-31 $426
2023-12-31 $553
2023-09-30 $403
2023-06-30 $300
2023-03-31 $424
2022-12-31 $483
2022-09-30 $438
2022-06-30 $494
2022-03-31 $474
2021-12-31 $407
2021-09-30 $424
2021-06-30 $578
2021-03-31 $416
2020-12-31 $384
2020-09-30 $383
2020-06-30 $-145
2020-03-31 $383
2019-12-31 $335
2019-09-30 $317
2019-06-30 $289
2019-03-31 $295
2018-12-31 $15
2018-09-30 $268
2018-06-30 $271
2018-03-31 $272
2017-12-31 $326
2017-09-30 $248
2017-06-30 $268
2017-03-31 $330
2016-12-31 $191
2016-09-30 $214
2016-06-30 $233
2016-03-31 $218
2015-12-31 $189
2015-09-30 $174
2015-06-30 $164
2015-03-31 $181
2014-12-31 $169
2014-09-30 $148
2014-06-30 $135
2014-03-31 $110
2013-12-31 $145
2013-09-30 $123
2013-06-30 $141
2013-03-31 $126
2012-12-31 $155
2012-09-30 $109
2012-06-30 $110
2012-03-31 $100
2011-12-31 $101
2011-09-30 $74
2011-06-30 $90
2011-03-31 $93
2010-12-31 $96
2010-09-30 $81
2010-06-30 $87
2010-03-31 $77
2009-12-31 $79
2009-09-30 $72
2009-06-30 $77
2009-03-31 $69
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $42.082B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.584B 24.71
Intuitive Surgical (ISRG) United States $193.049B 100.93
Alcon (ALC) Switzerland $43.825B 29.32
IQVIA Holdings (IQV) United States $36.452B 20.08
IDEXX Laboratories (IDXX) United States $34.535B 40.67
DexCom (DXCM) United States $30.463B 45.88
Waters (WAT) United States $22.843B 33.78
STERIS (STE) Ireland $21.623B 24.89
SONOVA HOLDING (SONVY) Switzerland $20.352B 0.00
Hologic (HOLX) United States $18.042B 19.49
Sysmex ADR (SSMXY) Japan $13.304B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $12.922B 13.27
Globus Medical (GMED) United States $11.657B 29.52
Penumbra (PEN) United States $9.369B 91.77
Masimo (MASI) United States $9.238B 44.70
Teleflex (TFX) United States $8.957B 14.28
Glaukos (GKOS) United States $7.920B 0.00
PROCEPT BioRobotics (PRCT) United States $4.988B 0.00
Integer Holdings (ITGR) United States $4.713B 26.71
Veracyte (VCYT) United States $3.329B 99.88
Inari Medical (NARI) United States $3.040B 0.00
TransMedics (TMDX) United States $2.910B 92.25
LivaNova (LIVN) United Kingdom $2.851B 16.46
Nihon Kohden (NHNKY) Japan $2.276B 17.29
Elekta AB (EKTAY) Sweden $2.261B 20.33
Tandem Diabetes Care (TNDM) United States $2.012B 0.00
Integra LifeSciences Holdings (IART) United States $1.897B 9.91
RxSight (RXST) United States $1.889B 0.00
Alphatec Holdings (ATEC) United States $1.486B 0.00
Pulse Biosciences (PLSE) United States $1.316B 0.00
Artivion (AORT) United States $1.237B 82.00
OPKO Health (OPK) United States $1.051B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.881B 14.97
Paragon 28 (FNA) United States $0.863B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.746B 0.00
IRadimed (IRMD) United States $0.683B 36.94
Mesa Laboratories (MLAB) United States $0.636B 15.00
OrthoPediatrics (KIDS) United States $0.629B 0.00
AxoGen (AXGN) United States $0.612B 0.00
SiBone (SIBN) United States $0.569B 0.00
Treace Medical Concepts (TMCI) United States $0.531B 0.00
Pacific Biosciences Of California (PACB) United States $0.523B 0.00
Semler Scientific (SMLR) United States $0.473B 27.82
Tactile Systems Technology (TCMD) United States $0.469B 25.38
Delcath Systems (DCTH) United States $0.380B 0.00
CVRx (CVRX) United States $0.372B 0.00
ClearPoint Neuro (CLPT) United States $0.341B 0.00
NeuroPace (NPCE) United States $0.316B 0.00
AngioDynamics (ANGO) United States $0.282B 0.00
Inogen (INGN) United States $0.231B 0.00
Accuray (ARAY) United States $0.224B 0.00
Sight Sciences (SGHT) United States $0.203B 0.00
Alpha Tau Medical (DRTS) Israel $0.196B 0.00
KORU Medical Systems (KRMD) United States $0.182B 0.00
Nevro (NVRO) United States $0.172B 0.00
Atossa Genetics (ATOS) United States $0.164B 0.00
Sensus Healthcare (SRTS) United States $0.139B 14.93
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
908 Devices (MASS) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.091B 0.00
LENSAR (LNSR) United States $0.087B 0.00
Vicarious Surgical (RBOT) United States $0.083B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
InspireMD (NSPR) Israel $0.077B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.072B 0.00
Monogram Orthopaedics (MGRM) United States $0.069B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
EnVVeno Medical (NVNO) United States $0.055B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.042B 0.00
Adagio Medical Holdings (ADGM) United States $0.039B 0.00
Spectral AI (MDAI) United States $0.036B 0.00
Biosig Technologies (BSGM) United States $0.031B 0.00
Precision Optics (POCI) United States $0.031B 0.00
Neuronetics (STIM) United States $0.030B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
NexGel (NXGL) United States $0.022B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.015B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
Autonomix Medical (AMIX) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00